Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a pilot study of surgical patients whose postoperative care will be augmented with a personalized risk prediction platform (CALYPSO app).
CALYPSO is a software platform that uses machine learning techniques to create personalized risk predictions for postoperative complications. Individual risk factors are then linked to best-practice interventions tailored to the individual patient. The investigator aims to test the hypothesis that using CALYPSO-augmented postoperative care will reduce complication rates in patients undergoing elective general surgery. Subjects undergoing surgery will be assigned to the CALYPSO intervention in the postoperative period.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CALYPSO-augmented | Patients' postoperative care will be augmented with the CALYPSO platform. |
| |
| Historical Control | Patients' postoperative care was performed using standard practice, before adopting the CALYPSO platform |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CALYPSO | Other | Software platform of machine-learning based predictive models of surgical complication. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Thirty Day Overall Complications | 30 days after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Thirty Day Mortality | 30 days after surgery | |
| Wound Complications | Includes superficial, deep, organ space infections, and wound dehiscence | 30 days after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients undergoing high risk general and oncologic abdominal surgery.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Zhifei Sun, MD | Duke University Department of Surgery | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C417209 | thiacloprid |
| D059039 | Standard of Care |
| ID | Term |
|---|---|
| D019984 | Quality Indicators, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017530 | Health Care Quality, Access, and Evaluation |
Not provided
Not provided
Not provided
Not provided
Not provided
| Standard Care | Behavioral | Previous standard of care based on surgeon judgement alone. |
|
| Cardiac Complications | includes myocardial infarction, cardiac arrest | 30 days after surgery |
| Respiratory Complications | includes unplanned reintubation, pneumonia, failure to wean from ventilator >48 hours after surgery | 30 days after surgery |
| Thrombotic complications | includes deep vein thrombosis, pulmonary emobolism | 30 days after surgery |
| Renal Complications | includes acute renal failure, renal failure requiring dialysis | 30 days after surgery |
| urinary tract infections | 30 days after surgery |
| Neurologic complications | includes stroke, peripheral nerve injury, coma | 30 days after surgery |
| Septic complications | includes sepsis and septic shock | 30 days after surgery |
| Unplanned reoperation | 30 days after surgery |
| unplanned readmission | 30 days after surgery |
| bleeding complications | needing at least 1 unit of pRBC | up to 72 hours after surgery |